| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.35 | 0.005 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.4 | 0.008 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |